Inventor · disambiguated record
James E. Brown
Also filed as: BROWN JAMES · BROWN JAMES E · BROWN JAMES ERNEST
15 granted patents·23 pending applications·1,343 citations·filing 1997–2023
94Inventor score
Files withDURECT CORP12SCHLUMBERGER TECHNOLOGY CORP10UNIV VIRGINIA COMMONWEALTH6BROWN JAMES E2ALZA CORP1
Top patents by PatentIndex Score
38 records- 0199US6071305ADirectional drug delivery stent and method of useALZA CORP·Filed 1997·Granted Jun 6, 2000·1k cites·21 claims
- 0297US9670764B2Heterogeneous proppant placement in a fracture with removable channelant fillSCHLUMBERGER TECHNOLOGY CORP·Filed 2014·Granted Jun 6, 2017·36 cites·33 claims
- 0395US10786517B2Uses of oxygenated cholesterol sulfates (OCS)UNIV VIRGINIA COMMONWEALTH·Filed 2019·Granted Sep 29, 2020·4 cites·14 claims
- 0494US6835194B2Implantable devices and methods for treatment of pain by delivery of fentanyl and fentanyl congenersDURECT CORP·Filed 2002·Granted Dec 28, 2004·148 cites·27 claims
- 0590US8956644B2Transdermal delivery systemsDURECT CORP·Filed 2012·Granted Feb 17, 2015·14 cites·32 claims
- 0688US11612609B2Uses of oxygenated cholesterol sulfates (OCS)UNIV VIRGINIA COMMONWEALTH·Filed 2020·Granted Mar 28, 2023·1 cites·21 claims
- 0788US9528354B2Downhole tool positioning system and methodSCHLUMBERGER TECHNOLOGY CORP·Filed 2013·Granted Dec 27, 2016·13 cites·20 claims
- 0883US8337883B2Transdermal delivery systemsYUM SU IL·Filed 2007·Granted Dec 25, 2012·5 cites·17 claims
- 0983US2023310458A1Uses of oxygenated cholesterol sulfates (ocs)UNIV VIRGINIA COMMONWEALTH·Filed 2023·Application pending·0 cites
- 1081US10272097B2Uses of oxygenated cholesterol sulfates (OCS)UNIV VIRGINIA COMMONWEALTH·Filed 2014·Granted Apr 30, 2019·3 cites·18 claims
- 1177US12281559B2Systems and methods of initiating energetic reactions for reservoir stimulationSCHLUMBERGER TECHNOLOGY CORP·Filed 2023·Granted Apr 22, 2025·0 cites·5 claims
- 1277US10202833B2Hydraulic fracturing with exothermic reactionSCHLUMBERGER TECHNOLOGY CORP·Filed 2013·Granted Feb 12, 2019·5 cites·19 claims
- 1375US2023372361A1Use of oxygenated cholesterol sulfates for treating inflammatory conditionsDURECT CORP·Filed 2021·Application pending·0 cites
- 1474US2023285416A1Use of oxygenated cholesterol sulfates for treating at least one of insulin resistance, diabetes, and prediabetesDURECT CORP·Filed 2021·Application pending·0 cites
- 1574US2023218639A1Use of oxygenated cholesterol sulfates for treating neurological conditions, neurodegenerative diseases, and addictionDURECT CORP·Filed 2021·Application pending·0 cites
- 1667US11808128B2Systems and methods of initiating energetic reactions for reservoir stimulationSCHLUMBERGER TECHNOLOGY CORP·Filed 2021·Granted Nov 7, 2023·0 cites·12 claims
- 1762US6638263B1Regulation of drug delivery through flow diversionDURECT CORP·Filed 1999·Granted Oct 28, 2003·72 cites·38 claims
- 1859US10815766B2Vertical drilling and fracturing methodologySCHLUMBERGER TECHNOLOGY CORP·Filed 2016·Granted Oct 27, 2020·1 cites·20 claims
- 1959US2021169902A1Use of oxygenated cholesterol sulfates (ocs) to treat inflammatory skin disease and skin lesionsUNIV VIRGINIA COMMONWEALTH·Filed 2020·Application pending·0 cites
- 2059US2018110739A1Transdermal Delivery SystemsDURECT CORP·Filed 2017·Application pending·0 cites
- 2158US2013273139A1Transdermal delivery systemsDURECT CORP·Filed 2013·Application pending·0 cites
- 2257US10954771B2Systems and methods of initiating energetic reactions for reservoir stimulationSCHLUMBERGER TECHNOLOGY CORP·Filed 2017·Granted Mar 23, 2021·0 cites·11 claims
- 2357US2008176785A1Controlled release compositionsBROWN JAMES E·Filed 2007·Application pending·0 cites
- 2456US2023181602A1Treatment of non-alcoholic steatohepatitis (nash)DURECT CORP·Filed 2021·Application pending·0 cites
- 2555US2017007549A1Transdermal Delivery SystemsDURECT CORP·Filed 2016·Application pending·0 cites
- 2655US2019374554A1Use of oxygenated cholesterol sulfates (ocs) to treat inflammatory skin disease and skin lesionsUNIV VIRGINIA COMMONWEALTH·Filed 2017·Application pending·0 cites
- 2754US2023141965A1Treatment of infectious diseasesDURECT CORP·Filed 2021·Application pending·0 cites
- 2853US2022378802A1Treatment of alcoholic hepatitisDURECT CORP·Filed 2020·Application pending·0 cites
- 2947US2008254086A1Controlled Release CompositionsBROWN JAMES E·Filed 2004·Application pending·0 cites
- 3045US2004054333A1Regulation of drug delivery through flow diversionFiled 2003·Application pending·0 cites
- 3144US2016053597A1Hydraulic fracturing while drilling and/or trippingSMITH INTERNATIONAL·Filed 2014·Application pending·0 cites
- 3243US2016040518A1Well treatment fluidsSCHLUMBERGER TECHNOLOGY CORP·Filed 2014·Application pending·0 cites
- 3343US2002193751A1Regulation of drug delivery through flow diversionFiled 2002·Application pending·0 cites
- 3442US2014151043A1Stabilized fluids in well treatmentSCHLUMBERGER TECHNOLOGY CORP·Filed 2013·Application pending·0 cites
- 3542US2004220529A1Apparatus and methods for activating a delivery deviceFiled 2003·Application pending·0 cites
- 3641US2015369029A1Compound cluster placement in fracturesSCHLUMBERGER TECHNOLOGY CORP·Filed 2014·Application pending·0 cites
- 3738US2013046066A1Method of preparing a polymer and compositions thereforJOHNSON MATTHEY PLC·Filed 2011·Application pending·0 cites
- 3837US2005070883A1Devices and methods for controlled delivery from a drug delivery deviceFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when James E. Brown files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →